Copyright Reports & Markets. All rights reserved.

Global and Japan Infectious Disease Diagnostics Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Molecular diagnostic test
    • 1.2.3 POC infectious disease diagnostics test
  • 1.3 Market by Application
    • 1.3.1 Global Infectious Disease Diagnostics Testing Market Share by Application: 2020 VS 2026
    • 1.3.2 Respiratory
    • 1.3.3 HIV
    • 1.3.4 HAIs
    • 1.3.5 Sexual health
    • 1.3.6 Tropical diseases
    • 1.3.7 Liver
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Infectious Disease Diagnostics Testing Market Perspective (2015-2026)
  • 2.2 Global Infectious Disease Diagnostics Testing Growth Trends by Regions
    • 2.2.1 Infectious Disease Diagnostics Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Infectious Disease Diagnostics Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Infectious Disease Diagnostics Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Infectious Disease Diagnostics Testing Players by Market Size
    • 3.1.1 Global Top Infectious Disease Diagnostics Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Infectious Disease Diagnostics Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global Infectious Disease Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Infectious Disease Diagnostics Testing Revenue
  • 3.4 Global Infectious Disease Diagnostics Testing Market Concentration Ratio
    • 3.4.1 Global Infectious Disease Diagnostics Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostics Testing Revenue in 2019
  • 3.5 Key Players Infectious Disease Diagnostics Testing Area Served
  • 3.6 Key Players Infectious Disease Diagnostics Testing Product Solution and Service
  • 3.7 Date of Enter into Infectious Disease Diagnostics Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Disease Diagnostics Testing Breakdown Data by Type (2015-2026)

  • 4.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2021-2026)

5 Infectious Disease Diagnostics Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Application (2015-2020)
  • 5.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Infectious Disease Diagnostics Testing Market Size (2015-2026)
  • 6.2 North America Infectious Disease Diagnostics Testing Market Size by Type (2015-2020)
  • 6.3 North America Infectious Disease Diagnostics Testing Market Size by Application (2015-2020)
  • 6.4 North America Infectious Disease Diagnostics Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Infectious Disease Diagnostics Testing Market Size (2015-2026)
  • 7.2 Europe Infectious Disease Diagnostics Testing Market Size by Type (2015-2020)
  • 7.3 Europe Infectious Disease Diagnostics Testing Market Size by Application (2015-2020)
  • 7.4 Europe Infectious Disease Diagnostics Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Infectious Disease Diagnostics Testing Market Size (2015-2026)
  • 8.2 China Infectious Disease Diagnostics Testing Market Size by Type (2015-2020)
  • 8.3 China Infectious Disease Diagnostics Testing Market Size by Application (2015-2020)
  • 8.4 China Infectious Disease Diagnostics Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Infectious Disease Diagnostics Testing Market Size (2015-2026)
  • 9.2 Japan Infectious Disease Diagnostics Testing Market Size by Type (2015-2020)
  • 9.3 Japan Infectious Disease Diagnostics Testing Market Size by Application (2015-2020)
  • 9.4 Japan Infectious Disease Diagnostics Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Infectious Disease Diagnostics Testing Market Size (2015-2026)
  • 10.2 Southeast Asia Infectious Disease Diagnostics Testing Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Infectious Disease Diagnostics Testing Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Infectious Disease Diagnostics Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Abbott Diagnostic
    • 11.1.1 Abbott Diagnostic Company Details
    • 11.1.2 Abbott Diagnostic Business Overview
    • 11.1.3 Abbott Diagnostic Infectious Disease Diagnostics Testing Introduction
    • 11.1.4 Abbott Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2015-2020))
    • 11.1.5 Abbott Diagnostic Recent Development
  • 11.2 Abbott
    • 11.2.1 Abbott Company Details
    • 11.2.2 Abbott Business Overview
    • 11.2.3 Abbott Infectious Disease Diagnostics Testing Introduction
    • 11.2.4 Abbott Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 11.2.5 Abbott Recent Development
  • 11.3 bioMérieux
    • 11.3.1 bioMérieux Company Details
    • 11.3.2 bioMérieux Business Overview
    • 11.3.3 bioMérieux Infectious Disease Diagnostics Testing Introduction
    • 11.3.4 bioMérieux Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 11.3.5 bioMérieux Recent Development
  • 11.4 Diasorin
    • 11.4.1 Diasorin Company Details
    • 11.4.2 Diasorin Business Overview
    • 11.4.3 Diasorin Infectious Disease Diagnostics Testing Introduction
    • 11.4.4 Diasorin Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 11.4.5 Diasorin Recent Development
  • 11.5 Roche Diagnostic
    • 11.5.1 Roche Diagnostic Company Details
    • 11.5.2 Roche Diagnostic Business Overview
    • 11.5.3 Roche Diagnostic Infectious Disease Diagnostics Testing Introduction
    • 11.5.4 Roche Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 11.5.5 Roche Diagnostic Recent Development
  • 11.6 Beckman Coulter
    • 11.6.1 Beckman Coulter Company Details
    • 11.6.2 Beckman Coulter Business Overview
    • 11.6.3 Beckman Coulter Infectious Disease Diagnostics Testing Introduction
    • 11.6.4 Beckman Coulter Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 11.6.5 Beckman Coulter Recent Development
  • 11.7 Becton, Dickinson and Company
    • 11.7.1 Becton, Dickinson and Company Company Details
    • 11.7.2 Becton, Dickinson and Company Business Overview
    • 11.7.3 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Introduction
    • 11.7.4 Becton, Dickinson and Company Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 11.7.5 Becton, Dickinson and Company Recent Development
  • 11.8 Bio-Rad Laboratories
    • 11.8.1 Bio-Rad Laboratories Company Details
    • 11.8.2 Bio-Rad Laboratories Business Overview
    • 11.8.3 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Introduction
    • 11.8.4 Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 11.8.5 Bio-Rad Laboratories Recent Development
  • 11.9 Cavidi
    • 11.9.1 Cavidi Company Details
    • 11.9.2 Cavidi Business Overview
    • 11.9.3 Cavidi Infectious Disease Diagnostics Testing Introduction
    • 11.9.4 Cavidi Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 11.9.5 Cavidi Recent Development
  • 11.10 Cepheid
    • 11.10.1 Cepheid Company Details
    • 11.10.2 Cepheid Business Overview
    • 11.10.3 Cepheid Infectious Disease Diagnostics Testing Introduction
    • 11.10.4 Cepheid Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 11.10.5 Cepheid Recent Development
  • 11.11 Corgenix
    • 10.11.1 Corgenix Company Details
    • 10.11.2 Corgenix Business Overview
    • 10.11.3 Corgenix Infectious Disease Diagnostics Testing Introduction
    • 10.11.4 Corgenix Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 10.11.5 Corgenix Recent Development
  • 11.12 Diaxonhit
    • 10.12.1 Diaxonhit Company Details
    • 10.12.2 Diaxonhit Business Overview
    • 10.12.3 Diaxonhit Infectious Disease Diagnostics Testing Introduction
    • 10.12.4 Diaxonhit Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 10.12.5 Diaxonhit Recent Development
  • 11.13 Eiken Chemical
    • 10.13.1 Eiken Chemical Company Details
    • 10.13.2 Eiken Chemical Business Overview
    • 10.13.3 Eiken Chemical Infectious Disease Diagnostics Testing Introduction
    • 10.13.4 Eiken Chemical Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 10.13.5 Eiken Chemical Recent Development
  • 11.14 EMD Millipore
    • 10.14.1 EMD Millipore Company Details
    • 10.14.2 EMD Millipore Business Overview
    • 10.14.3 EMD Millipore Infectious Disease Diagnostics Testing Introduction
    • 10.14.4 EMD Millipore Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 10.14.5 EMD Millipore Recent Development
  • 11.15 Epitope Diagnostic
    • 10.15.1 Epitope Diagnostic Company Details
    • 10.15.2 Epitope Diagnostic Business Overview
    • 10.15.3 Epitope Diagnostic Infectious Disease Diagnostics Testing Introduction
    • 10.15.4 Epitope Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 10.15.5 Epitope Diagnostic Recent Development
  • 11.16 EUROIMMUN
    • 10.16.1 EUROIMMUN Company Details
    • 10.16.2 EUROIMMUN Business Overview
    • 10.16.3 EUROIMMUN Infectious Disease Diagnostics Testing Introduction
    • 10.16.4 EUROIMMUN Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 10.16.5 EUROIMMUN Recent Development
  • 11.17 Gold Standard Diagnostics
    • 10.17.1 Gold Standard Diagnostics Company Details
    • 10.17.2 Gold Standard Diagnostics Business Overview
    • 10.17.3 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Introduction
    • 10.17.4 Gold Standard Diagnostics Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 10.17.5 Gold Standard Diagnostics Recent Development
  • 11.18 Hologic
    • 10.18.1 Hologic Company Details
    • 10.18.2 Hologic Business Overview
    • 10.18.3 Hologic Infectious Disease Diagnostics Testing Introduction
    • 10.18.4 Hologic Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 10.18.5 Hologic Recent Development
  • 11.19 Immunetics
    • 10.19.1 Immunetics Company Details
    • 10.19.2 Immunetics Business Overview
    • 10.19.3 Immunetics Infectious Disease Diagnostics Testing Introduction
    • 10.19.4 Immunetics Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 10.19.5 Immunetics Recent Development
  • 11.20 InBios International
    • 10.20.1 InBios International Company Details
    • 10.20.2 InBios International Business Overview
    • 10.20.3 InBios International Infectious Disease Diagnostics Testing Introduction
    • 10.20.4 InBios International Revenue in Infectious Disease Diagnostics Testing Business (2015-2020)
    • 10.20.5 InBios International Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Infectious Disease Diagnostics Testing Scope and Market Size
    Infectious Disease Diagnostics Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Diagnostics Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Molecular diagnostic test
    POC infectious disease diagnostics test

    Market segment by Application, split into
    Respiratory
    HIV
    HAIs
    Sexual health
    Tropical diseases
    Liver

    Based on regional and country-level analysis, the Infectious Disease Diagnostics Testing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Infectious Disease Diagnostics Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Abbott Diagnostic
    Abbott
    bioMérieux
    Diasorin
    Roche Diagnostic
    Beckman Coulter
    Becton, Dickinson and Company
    Bio-Rad Laboratories
    Cavidi
    Cepheid
    Corgenix
    Diaxonhit
    Eiken Chemical
    EMD Millipore
    Epitope Diagnostic
    EUROIMMUN
    Gold Standard Diagnostics
    Hologic
    Immunetics
    InBios International

    Buy now